Prostate Cancer-Drug Pipeline Analysis and Market Forecasts to 2015

Oct. 9, 2010 - PRLog -- "Prostate Cancer-Drug Pipeline Analysis and Market Forecasts to 2015" is an essential source of information and analysis on the global prostate cancer market. The report identifies the key trends shaping and driving the global prostate cancer market, a key segment within the pharma industry. The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shift in the market positioning of the existing market leaders. Most importantly, the report provides valuable insight on the pipeline products within the global prostate cancer sector.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis.

Scope
The scope of the report includes:
-Annualized global prostate cancer market revenues data from 2000 to 2008, forecast forward for 7 years to 2015.
-Geographic markets covered in this report include the US, the UK, Italy, Spain, Germany, France, and Japan.
-Pipeline analysis data providing a split across different phases, mechanism of action being developed and emerging trends.
-Analysis of the current and future market competition in the global prostate cancer market. Key market players covered include Sanofi-aventis, Pfizer Inc., AstraZeneca, Bristol-Myers Squibb and GlaxoSmithKline plc.
-Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.
-Key topics covered include strategic competitor assessment, market characterization, unmet needs and implications for future market associated with prostate cancer.

Reasons to buy
The report will enhance your decision making capability in a more rapid and time sensitive manner. It will allow you to:
-Develop and design your in-licensing and out-licensing strategies through review of pipeline products and technologies and by identifying companies with the most robust pipeline.
-Develop business strategies by understanding the trends shaping and driving the global prostate cancer market.
-Drive revenues by understanding key trends, innovative products and technologies, market segments and companies likely to impact the global prostate cancer market in future.
-Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
-Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
-Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
-What's the next big thing in the global prostate cancer market landscape? -Identify, understand and capitalize.



Table of Contents
1 Table of contents 3
1.1 List of Tables 5
1.2 List of Figures 5
2 Prostate Cancer: Market Characterization 6
2.1 Overview 6
2.1.1 Symptoms 6
2.1.2 Treatment 6
2.1.3 Epidemiology 7
2.2 Prostate Cancer Market Size 7
2.3 Prostate Cancer Market Forecast and CAGR 7
2.4 Drivers and Barriers for Prostate Cancer Market 8
2.4.1 Drivers for Prostate Cancer Market 9
2.4.2 Barriers for Prostate Cancer Market 9
2.5 Opportunity and Unmet Need 9
2.6 Key Takeaway 11
3 Prostate Cancer Market: Competitive Assessment 12
3.1 Overview 12
3.2 Strategic Competitor Assessment 12
3.3 Product Profile for the Major Marketed Products in the Prostate Cancer Market 12
3.3.1 Taxotere (docetaxel) 12
3.3.2 Eligard (leuprolide acetate) 13
3.3.3 Trelstar (triptorelin) 14
3.3.4 Firmagon (degarelix) 15
3.4 Key Takeaway 16
3.5 Major Marketed Products Comparison in Prostate Cancer Market 17
4 Prostate Cancer Market: Pipeline Assessment 18
4.1 Overview 18
4.2 Strategic Pipeline Assessment 18
4.2.1 Technology Trends Analytic Framework 18
4.3 Prostate Cancer Therapeutics-Promising Drugs Under Clinical Development 19
4.4 Molecule Profile for Promising Drugs under Clinical Development 20
4.4.1 Provenge (sipuleucel-T) 20
4.4.2 Denosumab 21
4.4.3 Aflibercept (VEGF Trap) 22
4.4.4 Ipilimumab 23
4.4.5 Abiraterone Acetate (CB7630) 23
4.5 Prostate Cancer Therapeutics Market-Clinical Pipeline by Therapeutic Class 24
4.6 Prostate Cancer Disease Pipeline-Pipeline by Clinical Phases of Development 25
4.6.1 Prostate Cancer Therapeutics-Phase III and Regulatory Filed Clinical Pipeline 26
4.6.2 Prostate Cancer Therapeutics-Phase II Clinical Pipeline 28
4.6.3 Prostate Cancer Therapeutics-Phase I Clinical Pipeline 34
4.6.4 Prostate Cancer Therapeutics-Preclinical Pipeline 36
4.6.5 Prostate Cancer Therapeutics-Drug Discovery Pipeline 36
4.7 Key Takeaway 37
5 Global Prostate Cancer Market: Implications for Future Market Competition 38
5.1 Strategic Competitor Assessment 39
6 Global Prostate Cancer Market: Future Players in Prostate Cancer Market 40
6.1 Introduction 40
6.2 Sanofi-aventis 40
6.2.1 Company Overview 40
6.2.2 Business Description 41
6.3 Pfizer Inc. 44
6.3.1 Company Overview 44
6.3.2 Business Description 45
6.4 AstraZeneca 47
6.4.1 Company Overview 47
6.4.2 Business Description 48
6.5 Bristol-Myers Squibb 50
6.5.1 Company Overview 50
6.5.2 Business Description 50
6.6 GlaxoSmithKline plc. 51
6.6.1 Company Overview 51
6.6.2 Business Description 52
7 Global Prostate Cancer Market: Appendix 55
7.1 Definitions 55
7.2 Acronyms 55
7.3 Research Methodology 55
7.3.1 Coverage 56
7.3.2 Secondary Research 56
7.3.3 Forecasting 57
7.3.4 Primary Research 60
7.3.5 Expert Panels 60
7.4 Contact Us 60
7.5 Disclaimer 60
7.6 Sources 62

List of Tables
Table 1:  Prostate Cancer Therapeutics Market, Global, Cancer Categorized by Disease Stage, 2009 6
Table 2:  Global Prostate Cancer Therapeutics Market, Historic Revenue ($m), 2000-2008 8
Table 3:  Global Prostate Cancer Therapeutics Market, Revenue Forecasts ($ m), 2009-2015 8
……

List of Figures
Figure 1:  Global Prostate Cancer Therapeutics Market Forecasts ($m), 2000-2015 8
Figure 2:  Prostate Cancer Therapeutics Market-Opportunity and Unmet Need, 2009 10
Figure 3:  Prostate Cancer Therapeutics Market-Strategic Competitor Assessment, 2009 12
……

# # #

ChinaCCM.com is China's leading industry consultancy expert offering industry intelligence and research solution, ChinaCCM Market Research Centre is a research division focusing on professional market survey and industry research.